HOCM, Hypertrophic Obstructive Cardiomyopathy Clinical Trial
Official title:
Endocardial Catheter CRyo-Ablation of Septal Hypertrophy for Hypertrophic Obstructive Cardiomyopathy
The purpose of the study is to perform endocardial catheter CRyo-Ablation to relieve the
LVOT obstruction in patients with Hypertrophic Obstructive Cardiomyopathy.
The investigators hypothesize that the investigators will be able to reduce > 50% of the
initial LVOT gradient. This will be considered as a successful procedure.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04349072 -
A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy
|
Phase 3 | |
| Recruiting |
NCT04230551 -
Reverse Remodeling After PTSMA in Severe But Asymptomatic LVOT Obstruction
|
N/A |